Verrica Pharmaceuticals Inc - Bathi resik saben saham sajrone patang kuartal pungkasan VRCA

Verrica Pharmaceuticals (VRCA) leads the development of progressive therapies for skin pathologies, focusing on unique topical agents. This chart reflects the market price and EPS TTM dynamics, which currently stand at 35.10. The business relies on US-based manufacturing capacities for antiviral products, utilizing exclusive component delivery technologies to ensure stable demand.
VRCA (Verrica Pharmaceuticals Inc.): rincian analitis lan laporan miturut indikator

Effective commercialization management of Ycanth and cost controls at Verrica Pharmaceuticals (VRCA) are directly reflected in the 12-month annual growth rate of earnings per share. This indicator measures the rate of change in net income per share relative to the previous year, allowing investors to assess the actual efficiency of business scaling and the stability of the company's fundamental value.